Company co.don AG Xetra

Equities

CNWK

DE000A1K0227

Pharmaceuticals

End-of-day quote Xetra 06:00:00 2022-09-29 pm EDT 5-day change 1st Jan Change
0.245 EUR -28.99% Intraday chart for co.don AG -25.76% -.--%

Business Summary

Co.don AG is a Germany-based company that is active in the tissue engineering and regenerative medicine industry. The Company manufactures cell-based biological drugs for the use in orthopedic and neurosurgical applications. Its products are used for the treatment of focal particular cartilage defects, lumbar disc herniation, non-union fractures and dental disorders. Those include co don chondrotransplant, which is used for cartilage treatment, particularly in the knee area; co don chondrosphere, which is a three-dimensional articular cartilage cultivated outside of the body; co don chondrotransplant DISC, for the regeneration of intervertebral discs, and co don osteotransplant DENT, which is an autologous bone cell transplant for dental applications. The Company is active domestically and in other European countries.

Sales per Business

EUR in Million2020Weight2021Weight Delta
Cell-based Pharmaceutical Products
100.0 %
6 100.0 % 10 100.0 % +57.28%

Sales per region

EUR in Million2020Weight2021Weight Delta
Germany
48.5 %
5 79.7 % 5 48.5 % -4.27%
China
33.9 %
-- 3 33.9 % -
Netherlands
6.9 %
1 15.3 % 1 6.9 % -28.57%
Austria
4.2 %
0 2.2 % 0 4.2 % +200.72%
Russia
3.8 %
-- 0 3.8 % -
United Kingdom
2.5 %
0 2.7 % 0 2.5 % +41.52%
Switzerland
0.2 %
0 0.1 % 0 0.2 % +185.71%

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 26,723,249 10,238,765 ( 38.31 %) 0 38.31 %

Shareholders

NameEquities%Valuation
LBBW Asset Management Investmentgesellschaft mbH
0.0581 %
15,527 0.0581 % 188 €
Baden-Württembergische Investment GmbH
0.0149 %
3,991 0.0149 % 48 €

Company contact information

co.don AG

Warthestrasse 21

14513, Teltow

+49 3328 43 46 0

http://www.codon.de
address co.don AG(CNWK)